NASAREL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nasarel, and what generic alternatives are available?
Nasarel is a drug marketed by Teva Branded Pharm and is included in one NDA.
The generic ingredient in NASAREL is flunisolide. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flunisolide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nasarel
A generic version of NASAREL was approved as flunisolide by BAUSCH on February 20th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NASAREL?
- What are the global sales for NASAREL?
- What is Average Wholesale Price for NASAREL?
Summary for NASAREL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Patent Applications: | 5,230 |
DailyMed Link: | NASAREL at DailyMed |
US Patents and Regulatory Information for NASAREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Branded Pharm | NASAREL | flunisolide | SPRAY, METERED;NASAL | 020409-001 | Mar 8, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NASAREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Branded Pharm | NASAREL | flunisolide | SPRAY, METERED;NASAL | 020409-001 | Mar 8, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Teva Branded Pharm | NASAREL | flunisolide | SPRAY, METERED;NASAL | 020409-001 | Mar 8, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Teva Branded Pharm | NASAREL | flunisolide | SPRAY, METERED;NASAL | 020409-001 | Mar 8, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NASAREL
See the table below for patents covering NASAREL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 1525181 | ⤷ Sign Up | |
Canada | 1075228 | UTILISATION DE LA FLUNISOLIDE DANS LE TRAITEMENT DES AFFECTIONS RESPIRATOIRES (FLUNISOLIDE TO TREAT RESPIRATORY DISEASES) | ⤷ Sign Up |
Hong Kong | 8580 | NEW FORM OF FLUNISOLIDE AND THE USE OF FLUNISOLIDE TO TREAT RESPIRATORY DISEASES | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |